Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
出版年份 2020 全文链接
标题
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 8, Pages 3022
出版商
MDPI AG
发表日期
2020-04-24
DOI
10.3390/ijms21083022
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The CaSR in Pathogenesis of Breast Cancer: A New Target for Early Stage Bone Metastases
- (2020) Souvik Das et al. Frontiers in Oncology
- Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Michael Gnant et al. LANCET ONCOLOGY
- Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
- (2019) Kathy Pan et al. JOURNAL OF CLINICAL ONCOLOGY
- From latency to overt bone metastasis in breast cancer: Potential for treatment and prevention
- (2019) Fernando Salvador et al. JOURNAL OF PATHOLOGY
- Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial
- (2019) Francesco Perrone et al. EUROPEAN JOURNAL OF CANCER
- FOXF2 reprograms breast cancer cells into bone metastasis seeds
- (2019) Shuo Wang et al. Nature Communications
- Clinical benefits of bone targeted agents in early breast cancer
- (2019) Robert Coleman BREAST
- Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
- (2019) Robert Coleman et al. LANCET ONCOLOGY
- Cancer Treatment and Bone Health
- (2018) Catherine Handforth et al. CALCIFIED TISSUE INTERNATIONAL
- Comparative study of neoadjuvant chemotherapy with and without Zometa® for management of locally advanced breast cancer with serum VEGF as primary endpoint: the NEOZOL study
- (2018) Loïc Lelièvre et al. Clinical Breast Cancer
- Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer
- (2018) Stephanie Strobl et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Zoledronate suppresses VEGF‑induced capillary tube formation and inhibits expression of interferon‑induced transmembrane protein‑1 in human umbilical vein endothelial cells
- (2018) Beom�Su Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial
- (2018) Janet Brown et al. JNCI-Journal of the National Cancer Institute
- Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial
- (2018) Janet Brown et al. JNCI-Journal of the National Cancer Institute
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
- (2018) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer
- (2018) Jules A. Westbrook et al. JOURNAL OF PATHOLOGY
- Metastatic bone disease: Pathogenesis and therapeutic options
- (2018) Stella D'Oronzo et al. Journal of Bone Oncology
- The value of biomarkers in bone metastasis
- (2017) Stella D'Oronzo et al. EUROPEAN JOURNAL OF CANCER CARE
- Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline
- (2017) Sukhbinder Dhesy-Thind et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial
- (2017) Robert Coleman et al. LANCET ONCOLOGY
- The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy
- (2017) Mekonnen Sisay et al. OncoTargets and Therapy
- Osteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro
- (2017) Mauro Cives et al. Oncotarget
- Characteristics and Significance of the Pre-metastatic Niche
- (2016) Yang Liu et al. CANCER CELL
- Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials
- (2016) J.R. Kroep et al. EUROPEAN JOURNAL OF CANCER
- CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
- (2016) Jules A. Westbrook et al. JNCI-Journal of the National Cancer Institute
- RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers
- (2016) Emma Nolan et al. NATURE MEDICINE
- Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents
- (2016) Ryota Tanaka et al. ONCOLOGIST
- CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
- (2016) Jules A. Westbrook et al. JNCI-Journal of the National Cancer Institute
- Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
- (2015) P. Hadji et al. ANNALS OF ONCOLOGY
- Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications
- (2015) S. D’Oronzo et al. CANCER TREATMENT REVIEWS
- Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
- (2015) Milica Pavlovic et al. JNCI-Journal of the National Cancer Institute
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
- (2015) LANCET
- Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
- (2015) Alison T. Stopeck et al. SUPPORTIVE CARE IN CANCER
- Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
- (2015) Milica Pavlovic et al. JNCI-Journal of the National Cancer Institute
- GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
- (2015) Yusuke Shiozawa et al. NEOPLASIA
- Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)
- (2014) A. Charehbili et al. ANNALS OF ONCOLOGY
- Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
- (2014) M. Gnant et al. ANNALS OF ONCOLOGY
- Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
- (2014) Robert Coleman et al. LANCET ONCOLOGY
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- Real-Time Intravital Imaging Establishes Tumor-Associated Macrophages as the Extraskeletal Target of Bisphosphonate Action in Cancer
- (2014) Simon Junankar et al. Cancer Discovery
- Effects of RANKL-Targeted Therapy in Immunity and Cancer
- (2014) Michael L. Cheng et al. Frontiers in Oncology
- Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood γδ T cells
- (2013) Shirin Kalyan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer
- (2013) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid
- (2012) P.G. Dedes et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer
- (2012) R L Aft et al. BRITISH JOURNAL OF CANCER
- The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasis
- (2012) Fanyan Meng et al. CANCER AND METASTASIS REVIEWS
- CXCL10 Promotes Osteolytic Bone Metastasis by Enhancing Cancer Outgrowth and Osteoclastogenesis
- (2012) J.-H. Lee et al. CANCER RESEARCH
- Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
- (2012) Alexander HG Paterson et al. LANCET ONCOLOGY
- Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
- (2011) Aya Kobayashi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients
- (2010) Florian Cabillic et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages
- (2010) A. J. Roelofs et al. CURRENT PHARMACEUTICAL DESIGN
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
- (2010) Rebecca Aft et al. LANCET ONCOLOGY
- Zoledronate Stimulates γδ T Cells in Prostate Cancer Patients
- (2010) Michio Naoe et al. ONCOLOGY RESEARCH
- Do RANKL inhibitors (denosumab) affect inflammation and immunity?
- (2010) S. Ferrari-Lacraz et al. OSTEOPOROSIS INTERNATIONAL
- Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor
- (2009) Zuzana Saidak et al. EXPERIMENTAL CELL RESEARCH
- Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow--a long-term follow-up
- (2008) I. J. Diel et al. ANNALS OF ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search